SCHEMBL29410794

SCHEMBL29410794

C=CC=CC=CC=CC(O)C1=C(C)CCCC1(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.34
▸ PTGS1 P23219 4/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ DRD3 P35462 2/20 0.34
▸ SLCO1B3 Q9NPD5 1/20 0.34
▸ SLCO1B1 Q9Y6L6 1/20 0.34
▸ HAO1 Q9UJM8 1/20 0.33
▸ CYP3A4 P08684 5/20 0.32
▸ APP P05067 4/20 0.32
▸ SNCA P37840 4/20 0.32
▸ ALOX15 P16050 3/20 0.32
▸ TSHR P16473 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ NR2E1 Q9Y466 1/20 0.32
▸ MAPT P10636 6/20 0.30
▸ RXRA P19793 5/20 0.30
▸ RARA P10276 4/20 0.30
▸ RARB P10826 4/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14879979 0.81 CYP1A2 (0.39) ALDH1A1PTGS1CYP1A2LMNADRD3
SCHEMBL11447770 0.80 CYP1A2 (0.38) ALDH1A1PTGS1CYP1A2LMNADRD3
SCHEMBL11356731 0.80 CYP1A2 (0.38) ALDH1A1PTGS1CYP1A2LMNADRD3
SCHEMBL11356723 0.80 CYP1A2 (0.38) ALDH1A1PTGS1CYP1A2LMNADRD3
SCHEMBL11447651 0.73 CYP1A2 (0.38) ALDH1A1PTGS1CYP1A2LMNADRD3
SCHEMBL11455628 0.71 CYP1A2 (0.36) ALDH1A1PTGS1CYP1A2LMNADRD3
SCHEMBL1628486 0.70 CYP1A2 (0.40) ALDH1A1PTGS1CYP1A2LMNADRD3
SCHEMBL11314530 0.68 CYP1A2 (0.36) ALDH1A1PTGS1CYP1A2LMNADRD3
SCHEMBL10378946 0.68 CYP1A2 (0.30) CYP1A2
SCHEMBL14880056 0.67 CYP1A2 (0.38) ALDH1A1PTGS1CYP1A2LMNADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022043407-A1 COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS LAOUAREM YOUSRA (FR) 2022-03-03 — — WO disclosed
Send feedback